Articles with public access mandates - Yohei DoiLearn more
Not available anywhere: 8
Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients
Y Fukuta, RR Muder, ME Agha, LG Clarke, MM Wagener, AM Hensler, ...
American journal of infection control 41 (12), 1249-1252, 2013
Mandates: US National Institutes of Health
Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant …
S Chusri, I Sakarunchai, N Kositpantawong, S Panthuwong, ...
International journal of antimicrobial agents 51 (4), 646-650, 2018
Mandates: US National Institutes of Health
Carbapenem-Resistant Acinetobacter baumannii: Concomitant Contamination of Air and Environmental Surfaces
LA Shimose, E Masuda, M Sfeir, AB Caban, MX Bueno, D Depascale, ...
infection control & hospital epidemiology 37 (7), 777-781, 2016
Mandates: US National Institutes of Health
Aliphatic Halogenase Enables Late‐Stage C− H Functionalization: Selective Synthesis of a Brominated Fischerindole Alkaloid with Enhanced Antibacterial Activity
Q Zhu, ML Hillwig, Y Doi, X Liu
ChemBioChem 17 (6), 466-470, 2016
Mandates: US National Institutes of Health
Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant …
S Chusri, K Singkhamanan, W Wanitsuwan, Y Suphasynth, ...
Journal of Infection and Chemotherapy 25 (9), 681-686, 2019
Mandates: US National Institutes of Health
Molecular epidemiology and spatiotemporal analysis of hospital-acquired Acinetobacter baumannii infection in a tertiary care hospital in southern Thailand
S Chusri, V Chongsuvivatwong, JI Rivera, K Silpapojakul, ...
Journal of Hospital Infection 95 (1), 53-58, 2017
Mandates: US National Institutes of Health
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates
KJ Westbrook, GS Chilambi, ME Stellfox, HR Nordstrom, Y Li, A Iovleva, ...
Journal of Antimicrobial Chemotherapy 79 (4), 801-809, 2024
Mandates: Wellcome Trust
C32 LUNG INJURY, ARDS, AND SEPSIS: Innate Host Factors Present In Serum Of Healthy Volunteers Control Growth Of Carbapenemase-Producing Klebsiella Pneumoniae
T Olonisakin, W Bain, H Li, Z Xiong, M Yu, Y Qu, M Hulver, Y Doi, J Lee
American Journal of Respiratory and Critical Care Medicine 195, 2017
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Available somewhere: 235
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
YY Liu, Y Wang, TR Walsh, LX Yi, R Zhang, J Spencer, Y Doi, G Tian, ...
The Lancet infectious diseases 16 (2), 161-168, 2016
Mandates: National Natural Science Foundation of China, UK Medical Research Council
The global epidemiology of carbapenemase-producing Enterobacteriaceae
D van Duin, Y Doi
Virulence 8 (4), 460-469, 2017
Mandates: US National Institutes of Health
Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens
ZA Qureshi, DL Paterson, BA Potoski, MC Kilayko, G Sandovsky, ...
Antimicrobial agents and chemotherapy 56 (4), 2108-2113, 2012
Mandates: US National Institutes of Health
Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae
D Van Duin, JJ Lok, M Earley, E Cober, SS Richter, F Perez, RA Salata, ...
Clinical Infectious Diseases 66 (2), 163-171, 2018
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)
MAEG El-Sayed Ahmed, LL Zhong, C Shen, Y Yang, Y Doi, GB Tian
Emerging microbes & infections 9 (1), 868-885, 2020
Mandates: National Natural Science Foundation of China
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae …
RK Shields, L Chen, S Cheng, KD Chavda, EG Press, A Snyder, ...
Antimicrobial agents and chemotherapy 61 (3), 10.1128/aac. 02097-16, 2017
Mandates: US National Institutes of Health
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective …
B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ...
The Lancet Infectious Diseases 17 (7), 726-734, 2017
Mandates: US National Institutes of Health, Government of Spain
Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia
RK Shields, MH Nguyen, L Chen, EG Press, BA Potoski, RV Marini, Y Doi, ...
Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 00883-17, 2017
Mandates: US National Institutes of Health
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
ZA Qureshi, LE Hittle, JA O'Hara, JI Rivera, A Syed, RK Shields, ...
Clinical infectious diseases 60 (9), 1295-1303, 2015
Mandates: US National Institutes of Health
Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections
RK Shields, BA Potoski, G Haidar, B Hao, Y Doi, L Chen, EG Press, ...
Clinical Infectious Diseases 63 (12), 1615-1618, 2016
Mandates: US National Institutes of Health
Aminoglycoside resistance: the emergence of acquired 16S ribosomal RNA methyltransferases
Y Doi, J Wachino, Y Arakawa
Infectious Disease Clinics 30 (2), 523-537, 2016
Mandates: US National Institutes of Health
Procalcitonin-guided use of antibiotics for lower respiratory tract infection
DT Huang, DM Yealy, MR Filbin, AM Brown, CCH Chang, Y Doi, ...
New England Journal of Medicine 379 (3), 236-249, 2018
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program